Paper 85 - EPIGENETIC BARRIERS AND OPPORTUNITIES FOR REPROGRAMMING IN DEDIFFERENTIATED LIPOSARCOMA

Author(s)

• 

  Erica M. Pimenta, MD, PhD

  Instructor of Medicine
  Dana-Farber Cancer Institute
  Needham, Massachusetts, United States

  Slides

Co-Author(s)

• AG

  Amanda Garza, PhD

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• SC

  Sabrina Camp, MS

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• JP

  Jihye Park, PhD

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• SH

  Samantha Hoffman, BA

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• LV

  Laura Valderrabano, BA

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• JF

  Jingxin Fu, PhD

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• KB

  Kevin Bi, BA

  Broad Institute
  Boston, Massachusetts, United States
• JK

  Julie Karam, BA

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• BT

  Breanna Titchen, BA

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• MK

  Melin Khandekar, MD, PhD

  Massachusetts General Hospital
  Boston, Massachusetts, United States
• ES

  Erin Shannon, BA

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• YK

  Yun Jee Kang, MD

  Brigham and Women's Hospital
  Boston, Massachusetts, United States
• AN

  Anwesha Nag, PhD

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• AT

  Aaron R. Thorner, PhD

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• 

  Chandrajit P. Raut, MD, MS (he/him/his)

  Surgical Oncologist
  Brigham and Women's Hospital
  Boston, Massachusetts, United States
• JH

  Jason L. Hornick, MD, PhD

  Professor of Pathology
  Brigham and Women's Hospital
  Boston, Massachusetts, United States
• 

  Priscilla Merriam, MD

  Medical Oncologist
  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• 

  Nicole L. Solimini, PhD (she/her/hers)

  Scientific Director, David Liposarcoma Research Initiative
  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• 

  Suzanne George, MD (she/her/hers)

  Chief
  Division of Sarcoma, Dana-Farber Cancer Institute – Sarcoma Center
  Boston, Massachusetts, United States
• 

  George Demetri, MD

  Director, Sarcoma Center and Ludwig Center at Harvard
  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• EV

  Eliezer Van Allen, MD

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States